发明名称 Anvendelse af heparinaser til at mindske inflammatoriske responser
摘要 Heparinase enzymes can be used as a medical treatment to reduce localized inflammatory responses. Treatment of activated endothelium with heparinase inhibits leukocyte rolling, adhesion and extravasation. Most of the heparin and heparan sulfate on endothelial cell surfaces and in basement membranes is degraded by exposure to heparinase. In addition, immobilized chemokines, which are attached to heparin/heparan sulfate on activated endothelium are solubilized by heparinase digestion. Heparinase can be infused into the vascular system to inhibit accumulation of leukocytes in inflamed tissue and decrease damage resulting from localized inflammations. Targeting of heparinase to activated endothelium can be accomplished through localized administration and/or use of genetically engineered heparinase containing endothelium ligand-binding domains.
申请公布号 DK0852491(T3) 申请公布日期 2004.12.20
申请号 DK19960936052T 申请日期 1996.09.27
申请人 BIOMARIN PHARMACEUTICAL INC 发明人 BENNETT, D., CLARK;CAUCHON, ELIZABETH;FINK, DOMINIQUE;GROUIX, BRIGETTE;HSIA, ARIANE;DANAGHER, PAMELA;ZIMMERMAN, JOSEPH
分类号 A61K38/00;A61K9/14;A61K31/00;A61K38/46;A61K38/47;A61K39/395;A61K45/00;A61K47/48;A61P9/10;A61P29/00;A61P43/00;C12N9/24;C12N9/88;C12N9/96;(IPC1-7):A61K9/14 主分类号 A61K38/00
代理机构 代理人
主权项
地址